Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of Ophthalmology Times.
COPHy 2023: New restorative therapiesMarch 24th 2023
In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.
APAO 2023: Beveled tip probe added to arsenal for retinal detachment vitrectomyFebruary 24th 2023
Yusuke Oshima, MD, PhD, in a presentation at the 38th Asia-Pacific Academy of Ophthalmology Congress, Kuala Lumpur, Malaysia, discussed the advantages of using a beveled-tip ultra-speed probe for complete vitreous shaving during retinal detachment vitrectomies.
APAO 2023: Step therapy from Bevacizumab to Aflibercept for DMEFebruary 24th 2023
Voraporn Chaikitmongkol, MD, discussed step therapy and reported the results of a major study, the Diabetic Retinopathy Clinical Research (DRCR) Protocol AC, at the 38th Asia-Pacific Academy of Ophthalmology Congress, in Kuala Lumpur, Malaysia.
APAO 2023: Looking at anatomic outcomes in matched comparison: TENAYA and LUCERNE dataFebruary 23rd 2023
Greater anatomic improvements (central subfield thickness reduction, proportion with absence of subretinal fluid and intraretinal fluid) were seen with faricimab versus aflibercept during the matched dosing period (week 4, week 8, and week 12).
FDA: Apellis' pegcetacoplan approved for the treatment of geographic atrophyFebruary 17th 2023
Apellis has received FDA approval for intravitreal pegcetacoplan (SYFOVRE) to treat geographic atrophy secondary to AMD. This news follows the submission of the 24-month phase 3 data in November 2022.
Networking and social activities abound for APAO delegatesFebruary 15th 2023
The agenda includes the Opening Ceremony, Women in Ophthalmology Luncheon, and Young Ophthalmologists’ Night, and that's only a sampling. The results of the APAO-Asia-Pacific Ocular Imaging Competition will also be announced.
Angiogenesis 2023: The tides of AMD reversed with drug targeting mitochondria to improve photopic visionFebruary 10th 2023
In a presentation at the Angiogenesis, Exudation, and Degeneration 2023 meeting hosted by Bascom Palmer Eye Institute, Baruch Kupperman, MD, PhD, detailed research in which investigators evaluated risuteganib for safety and effectiveness in patients with dry AMD.
Angiogenesis 2023: The mystery of geographic atrophy shifts with dataFebruary 10th 2023
In a presentation at the 2023 Angiogenesis, Exudation, and Degeneration program, Usha Chakravarthy, PhD, FRCOphth, CBE, presented data from the trial of lampalizumab, which is peeling back some of the mystery shrouding geographic atrophy.
Angiogenesis 2023: Using ophthalmic artery angioplasty to treat AMDFebruary 10th 2023
In a presentation at Bascom Palmer’s 2023 Angiogenesis, Exudation, and Degeneration conference in Miami, Pedro Lylyk, MD, said ophthalmic artery angioplasty could prove to be a treatment option for patients diagnosed with age-related macular degeneration.
Angiogenesis 2023: Comparing GA phenotypes and progression rates in Asians, non-AsiansFebruary 10th 2023
A study conducted by Gemmy Cheung, MBBS, FRCOphth and colleagues shows geographic atrophy (GA) lesion phenotypes, associated features, and growth rates differ between Asians and non-Asians.
CLOSE study outlines updated surgical classification for the treatment of large full-thickness macular holesFebruary 6th 2023
According to investigators pointed out that while good surgical results are obtained with small and medium-sized macular holes, it is important to determine the hole diameters at which the success rates of conventional surgery begin to decline.
Investigators identify connection between articles published before ophthalmology residency, future career pathJanuary 14th 2023
In the study, investigators conducted a cross-sectional study with the goal of evaluating a correlation between the number of peer-reviewed publications published before a residency and the subsequent peer-reviewed publications or career choices of doctors who graduated from an ophthalmology residency program.
ORION-1 biodegradable dexamethasone implant: Sustained visual improvement and decreased retinal thickening in CRVO and BRVOJanuary 8th 2023
Investigators concluded that both formulations of AR-1105 were well-tolerated and provided clinically meaningful and sustained visual improvements in vision and decreased retinal thickening despite that some patients had difficult-to-treat BRVO or CRVO with longstanding edema.